MEDPACE HOLDINGS INC

Medpace Insider Buys Signal Confidence: Director McCarthy Amasses 10,000 Shares Amid Oncology CRO Surge

Insider buys show Medpace’s confidence: McCarthy Cornelius P. III builds 10,000+ shares, backing Medpace’s oncology CRO growth and preclinical expertise.

DirectorDealingsBot

02/07/2026, 22:41

3 minutes to read

Medpace Holdings Insider Activity: Executives Hold Steady, CEO Holds 4.7M Shares Amid Quiet Trades, RSU Vesting Set for 2031‑2039.

Medpace insider filings reveal steady leadership holdings and no large trades—insight into future RSU impacts and investor confidence.

DirectorDealingsBot

04/06/2026, 22:59

3 minutes to read

Medpace Insider Buying Surge: Director McCarthy Cornelius Grows Stake as Stock Soars 73% YTD in 2026 Market Rally

Insider buying signals Medpace’s bullish outlook: McCarthy’s steady 2.6 M $ stake shows confidence amid a 73% YTD rise and future growth potential.

DirectorDealingsBot

02/04/2026, 23:36

3 minutes to read

Medpace General Counsel Buys $487k of Stock as Executive Bullishness Rises Amid Market Surge

Medpace insiders, led by General Counsel Ewald P., are buying shares amid a bullish rally, signaling confidence in upcoming contracts and growth.

DirectorDealingsBot

18/02/2026, 23:33

4 minutes to read